NASDAQ: UTMDUtah Medical Products Revenue
Utah Medical Products revenue was $40.90M for the trailing 12 months ending Dec 31, 2024, with -13.5% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $9.2M, down 8.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UTMD annual revenue was $40.9M, with -18.6% growth year-over-year.
UTMD past revenue growth
How has UTMD's revenue growth performed historically?
Company
-18.56%
Industry
10.75%
Market
20.27%
UTMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
UTMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
UTMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
UTMD revenue history
Current Revenue
$40.9M
Current Earnings
$13.9M
Current Profit Margin
33.9%
UTMD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when UTMD announces revenue.
UTMD Revenue History By Year
| UTMD Yearly Revenue | UTMD Revenue | UTMD Change | UTMD Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $40.90M | -$9.32M | -18.56% |
| 2023-12-31 | $50.22M | -$2.06M | -3.93% |
| 2022-12-31 | $52.28M | $3.23M | +6.58% |
| 2021-12-31 | $49.05M | $6.88M | +16.30% |
| 2020-12-31 | $42.18M | -$4.73M | -10.08% |
| 2019-12-31 | $46.90M | $4.91M | +11.68% |
| 2018-12-31 | $42.00M | $584.00k | +1.41% |
| 2017-12-31 | $41.41M | $2.12M | +5.38% |
| 2016-12-31 | $39.30M | -$859.00k | -2.14% |
| 2015-12-31 | $40.16M | -$1.12M | -2.72% |
| 2014-12-31 | $41.28M | $785.00k | +1.94% |
| 2013-12-31 | $40.49M | -$1.06M | -2.55% |
| 2012-12-31 | $41.55M | $3.69M | +9.75% |
| 2011-12-31 | $37.86M | $12.74M | +50.71% |
| 2010-12-31 | $25.12M | -$795.00k | -3.07% |
| 2009-12-31 | $25.92M | -$1.87M | -6.72% |
| 2008-12-31 | $27.78M | -$720.00k | -2.53% |
| 2007-12-31 | $28.50M | -$251.00k | -0.87% |
| 2006-12-31 | $28.75M | $1.06M | +3.83% |
| 2005-12-31 | $27.69M | $1.21M | +4.56% |
| 2004-12-31 | $26.49M | -$652.00k | -2.40% |
| 2003-12-31 | $27.14M | -$224.00k | -0.82% |
| 2002-12-31 | $27.36M | $407.00k | +1.51% |
| 2001-12-31 | $26.95M | -$239.00k | -0.88% |
| 2000-12-31 | $27.19M | -$2.25M | -7.65% |
| 1999-12-31 | $29.44M | $1.77M | +6.38% |
| 1998-12-31 | $27.68M | $3.41M | +14.03% |
| 1997-12-31 | $24.27M | -$14.40M | -37.24% |
| 1996-12-31 | $38.67M | -$3.37M | -8.00% |
| 1995-12-31 | $42.04M | N/A | N/A |
| 1994-12-31 | N/A | N/A | N/A |
Utah Medical Products Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.